 The substance is intended for subcutaneous injection and intravenous infusion, and indirectly inhibits aggregation, adhesion, and release of thrombocytes mediated through the action of a fibrinogen degradation product (FDP).It also cleaves and therefore inactivates a significant part of circulating plasma fibrinogen.Fibrinogen is often found in increased concentrations in arteriae with impaired circulation.